Carregando...
Targeting cyclooxygenase enzyme for the adjuvant COVID‐19 therapy
Despite vigorous efforts, the COVID‐19 pandemic continues to take a toll on the global health. The contemporary therapeutic regime focused on the viral spike proteins, viral 3CL protease enzyme, immunomodulation, inhibition of viral replication, and providing a symptomatic relief encouraged the repu...
Na minha lista:
| Publicado no: | Drug Dev Res |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8013002/ https://ncbi.nlm.nih.gov/pubmed/33496060 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21794 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|